PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AM7 | Ann: Drilling indicate increased Li Grade at Bitterwasser brines | 05/04/24 | 7 | 3.2K | |||
|
|||||||
AM7 | Ann: Interim Financial Report 31 December 2023 | 02/04/24 | 2 | 855 | |||
|
|||||||
AM7 | Ann: Quarterly Activities/Appendix 5B Cash Flow Report | 02/02/24 | 4 | 1.5K | |||
|
|||||||
AM7 | Ann: Mine Construction Progress at Swanson | 02/02/24 | 0 | 461 | |||
|
|||||||
AM7 | Ann: Li infill Assay results point to updated Mineral Resource | 01/02/24 | 0 | 342 | |||
|
|||||||
AM7 | Ann: Drilling commenced at Bitterwasser Lithium in brines project | 23/01/24 | 5 | 2.6K | |||
|
|||||||
AM7 | Swanson Tantalite Mine progress | 05/01/24 | 2 | 1.0K | |||
|
|||||||
AM7 | Ann: Assays pending and drilling commences Li project | 01/12/23 | 0 | 612 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |